RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative
a study on Chronic Obstructive Pulmonary Disease
Summary
- Eligibility
- for people ages 40-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- Prescott Woodruff, MD, MPH
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Prescott Woodruff, MD, MPH
II. The identification of molecular sub-phenotypes of asthma and COPD III. Mechanisms of airway inflammation and remodeling in lung diseases IV. Development of blood-based diagnostic tests for lung disease using genomic approaches
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of Michigan
- Links
- Pulmonary Trials Cooperative website, containing information regarding RETHINC and other studies included in the Pulmonary Trials Cooperative
- ID
- NCT02867761
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated